In December 2019, a new virus emerged in China and rapidly spread worldwide, raising serious international concerns, especially from the World Health Organization (WHO). This highly contagious infectious disease, later dubbed COVID-19, created an unprecedented global pandemic.

First cases diagnosed in France (2/10)
In France, the first confirmed cases were reported at the end of January 2020. About twenty days later, the country recorded its first deaths linked to the virus.

Containment (3/10)
A national lockdown was introduced on March 17, 2020. Although it was lifted less than two months later, mask wearing became mandatory.
At the same time, the authorities, in collaboration with the Institut Pasteur, launched a massive vaccination campaign.

Many Questions (4/10)
Several pharmaceutical companies, including Pfizer, AstraZeneca, Moderna, and Johnson & Johnson, have developed vaccines in record time.
This has raised many questions and debates about their safety, efficacy, and long-term effects.

Confirmed adverse reactions (5/10):
After millions of doses administered and nearly five years of data, specialists have reported known side effects such as high blood pressure, myocarditis/pericarditis, allergic reactions, and heavy menstrual bleeding.
Most of these effects remain rare but are documented in the scientific literature.

Serious side effects? (6/10)
To this day, some people, including scientists, continue to question a possible link between COVID-19 vaccines and various health problems.
A recent large-scale study has explored this issue further.

This study was conducted by the Global Immunization Data Network and involved more than 99 million people in eight countries: Argentina, Australia, Canada, France, Denmark, Finland, New Zealand, and Scotland.
Its findings were published in the scientific journal Vaccine.

Researchers’ comments (8/10):
“Most of the vaccinated people were between the ages of 20 and 59, and France is the country where the largest number of doses have been administered,” the researchers explain. The vaccines studied were produced by Pfizer, Moderna, and AstraZeneca.
These results fuel ongoing debates among healthcare professionals and patients.

Guillain-Barré syndrome and cerebral venous thrombosis (9/10)
Researchers observed an increase in cases of Guillain-Barré syndrome (GBS) and cerebral venous thrombosis (CVT) after the first dose of the AstraZeneca vaccine.

Guillain-Barré syndrome usually causes progressive muscle weakness.
Cerebral venous thrombosis occurs when a blood clot forms in a vein in the brain, blocking blood flow.

French basketball player Victor Wembanyama had already suffered from some form of thrombosis, which forced him to end his season.

Further research is needed (10/10)
Additionally, all vaccines have been shown to increase the risk of myocarditis and pericarditis – inflammation of the heart muscle or its surrounding tissue – although these events remain rare.

“Other issues requiring further research have been identified,” the journal said.
The researchers emphasize that further investigation is needed to fully understand the link between vaccination and these adverse effects.